Galectin Therapeutics Inc (GALT)

3.06 +0.22 (+7.75%) USD  |  NASDAQ  |  May 15, 16:00
3.12 +0.06 (+1.96%) After-Hours: 20:00
More

Galectin Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for GALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2020. Upgrade now.
Date Value
April 01, 2024 --
November 14, 2023 --
March 31, 2023 --
May 17, 2022 --
April 01, 2022 --
November 16, 2021 --
August 17, 2021 --
Date Value
May 18, 2021 --
April 16, 2021 --
November 11, 2020 --
October 07, 2020 --
May 22, 2020 --
March 17, 2020 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

--
Minimum
Mar 17 2020
Upgrade
Maximum
Apr 01 2024
Upgrade
Average
--
Median
Mar 17 2020

Revenue Estimates for Next Fiscal Year Benchmarks

Madrigal Pharmaceuticals Inc Upgrade
Viking Therapeutics Inc Upgrade
89bio Inc Upgrade
Terns Pharmaceuticals Inc Upgrade
Enanta Pharmaceuticals Inc Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade